Filing Flows › BridgeBio Pharma (BBIO) › Who owns the stock
Who owns BridgeBio Pharma (BBIO) stock
453 funds reported BridgeBio Pharma (BBIO) shares in their latest 13F filings, worth $15.3B in all. The largest holder is Vanguard Group ($1.3B). Last quarter 223 funds added to their stakes and 222 cut them. Members of Congress and other officials disclosed 6 trades (5 buys, 1 sales).
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Group | 16,862,691 | $1.3B | increase | 2025-12-31 |
| Jupiter Topco LLC | 14,110,278 | $1.1B | base | 2026-06-30 |
| Kohlberg Kravis Roberts & Co. L.P. | 13,260,971 | $988M | unchanged | 2026-06-30 |
| Janus Henderson Group | 13,179,013 | $979M | increase | 2026-03-31 |
| BlackRock | 10,287,156 | $766M | decrease | 2026-06-30 |
| Viking Global Investors LP | 9,949,219 | $741M | decrease | 2026-06-30 |
| Vanguard Capital Management LLC | 7,898,973 | $588M | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 7,656,722 | $570M | decrease | 2026-06-30 |
| Wellington Management Group LLP | 5,308,924 | $395M | increase | 2026-06-30 |
| Two Sigma Investments, LP | 4,722,185 | $352M | increase | 2026-06-30 |
| Aisling Capital Management LP | 4,589,611 | $342M | decrease | 2026-06-30 |
| State Street | 4,435,932 | $330M | decrease | 2026-06-30 |
| Citadel Advisors LLC | 3,760,028 | $280M | increase | 2026-06-30 |
| Invesco | 3,700,934 | $276M | decrease | 2026-06-30 |
| D. E. Shaw | 3,633,007 | $271M | increase | 2026-06-30 |
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2026-09-29 | Gilbert Cisneros | partial sale | $1K–$15K |
| 2026-05-11 | Gilbert Cisneros | purchase | $1K–$15K |
| 2026-04-29 | Gilbert Cisneros | purchase | $1K–$15K |
| 2026-03-19 | Gilbert Cisneros | purchase | $1K–$15K |
| 2026-03-18 | Gilbert Cisneros | purchase | $1K–$15K |
| 2026-03-03 | Gilbert Cisneros | purchase | $1K–$15K |
BridgeBio Pharma's latest quarter
BridgeBio Pharma, Q3 2026: revenue $353M (+193% year over year), operating margin -3.3%, net loss $60.5M, operating cash flow −$44.2M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most BBIO stock?
By the latest 13F filings: Vanguard Group ($1.3B); Jupiter Topco LLC ($1.1B); Kohlberg Kravis Roberts & Co. L.P. ($988M); Janus Henderson Group ($979M); BlackRock ($766M).
Has Congress traded BBIO stock?
Officials disclosed 6 trades on file: 5 buys and 1 sales. The latest: Gilbert Cisneros, partial sale on 2026-09-29.
What is the short interest in BBIO?
19,997,556 shares were sold short at the 2026-10-15 settlement, 1.66% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.